Free amino acid concentrations of serum in patients with hepatic diseases with special reference to hepatic coma
โ Scribed by Onodera, S. ;Kaito, I. ;Sato, S. ;Ishii, T. ;Hashimoto, K.
- Publisher
- Springer-Verlag
- Year
- 1973
- Tongue
- English
- Weight
- 62 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The concentration of hyaluronan was measured in the serum from patients with tumors. The patients were divided into nine groups: two control groups, i.e., those with benign tumors and those having undergone radical surgery; and seven groups of patients with untreated malignant conditions, i.e, mesot
Sera of patients with hepatic encephalopathy strongly inhibit the specific binding of y-aminobutyric acid to synaptic membranes. In a previous study, this inhibition of specific y-aminobutyric acid binding was attributed to y-aminobutyric acid itself, and it was assumed that serum y-aminobutyric aci
Lamivudine is effective in suppressing replication of hepatitis B virus (HBV). However, the emergence of HBV variants resistant to lamivudine is a concern. Lamivudine resistance has been attributed mainly to a substitution of isoleucine or valine for methionine at residue 550 (M550I or M550V) in the